Dr. Ivan Jose Suner, MD

Dr. Suner practices at Retina Associates of Florida, P.A. in Tampa, Florida.

Dr. Suner's NPI, 1164522793, was assigned on September 24, 2006. Dr. Suner graduated from Yale School of Medicine in 1992. Dr. Suner holds Florida license ME 64994.

Dr. Suner's primary practice is Retina Associates of Florida, P.A., at 602 S Macdill Ave, Tampa, FL 33609 in Hillsborough County. The practice phone is (813) 875-6373.

Dr. Suner's primary practice is Retina Associates of Florida, P.A. in Tampa, Florida. Dmand AI also links Dr. Suner to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suner practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Suner's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Suner is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Suner's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hypertensive retinopathy, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Suner treats.

CMS data shows 59,068 Medicare services from Dr. Suner across 17 procedure codes in 2024, for 1,003 Medicare patients. Medicare paid $2,121,953 for them.

CMS counts 1,003 Medicare patients who saw Dr. Suner in 2024. The largest group is 75 to 84, with 416 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Suner's median patient age at 71, with 54% women.

In 2024, Dr. Suner wrote 504 Medicare Part D claims for 133 patients. 61% of them were for generic drugs. CMS names the drug for 419 of them, across 10 drugs with 11 or more claims each, at $20,923 in total drug cost. In 2023, CMS named 337 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Suner for performance year 2024, reported as part of a group. Dr. Suner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of cataract surgery by Dr. Suner, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Suner. The most frequent topics are Cell Count, Mice, Inbred C57BL and Choroid. Dr. Suner has published most often in Invest Ophthalmol Vis Sci. Dr. Suner's most frequent co-authors are Karl G. Csaky, MD, David S. Greenfield, MD and Paul F. Palmberg, MD.

Dmand AI links Dr. Suner to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Diabetic Retinopathy, Retinal Vein Occlusion and Diabetic Angiopathies. Retina Associates of Florida, P.A. sponsors the most, 2. Open Payments lists research payments to Dr. Suner that name 1 trial.

CMS Open Payments shows 761 general payments to Dr. Suner from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Genentech, Inc. paid the most, $293,065. It also lists 23 research payments totaling $52,232 from 2018 to 2025, naming 1 clinical trial.

Dmand AI lists 17 awards for Dr. Suner, most recently Senior Honor Award in 2010.

Dr. Suner graduated from Yale School of Medicine in 1992. Dr. Suner is a member of AAO.

Dr. Suner is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.